fda approved weight loss glp-1 A big win for Wegovy: drug semaglutide first in history to gain approval for reducing heart risks FDA approves new GLP-1 weight

Semaglutide (GLP-1 RA) medications are a once-weekly injection prescribed to treat adults with type 2 diabetes

10.1161/JAHA.123.033572 J Am Heart Assoc

Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease

WEIGHT EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 Exogenous GLP-1 was soon demonstrated to have other effects of interest in relation to T2DM, most importantly an inhibitory effect on appetite and food intake [9]

There should be more tolerance of the fact that you can be very healthy at a range of weights, Dushay says

Individual timelines vary based on starting weight, dose, and genetics